What is the current Vietnam Insulin Drug And Delivery Device Market size?

The Vietnam Insulin Drug And Delivery Device Market is projected to register a CAGR of greater than 2% during the forecast period (2024-2029) Read More

Who are the key players in Vietnam Insulin Drug And Delivery Device Market?

Novo Nordisk, Sanofi, Eli Lilly, Medtronics and Roche are the major companies operating in the Vietnam Insulin Drug And Delivery Device Market. Read More

What years does this Vietnam Insulin Drug And Delivery Device Market cover?

The report covers the Vietnam Insulin Drug And Delivery Device Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vietnam Insulin Drug And Delivery Device Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vietnam Insulin Drug And Delivery Device Market Share

Statistics for the 2023 & 2024 Vietnam Insulin Drug And Delivery Device market share, created by Mordor Intelligence™ Industry Reports. Vietnam Insulin Drug And Delivery Device share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Vietnam Insulin Drug And Delivery Device Industry

The market is highly consolidated, with three major manufacturers holding a global market presence and the remaining manufacturers confined to other local or region-specific manufacturers. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have the alliance to develop and commercialize Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.